Skip to main content
Caplight Logo









SynapCell

SynapCell

Private
FranceHealthcare & Life Scienceshttps://synapcell.com/

Last Round

Grant

Jan 10, 2023

Total Funding Raised

$1.99M

Company Overview

SynapCell is a biotechnology company that operates as a preclinical contract research organization specializing in translational EEG to evaluate drug candidates for central nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

preclinical CROin vivo EEGCNS drug discoveryEEGCROdrug efficacy testingpreclinical servicestranslational biomarkersAI drug discoverypharmaco-EEGqEEGdrug candidate de-riskingcontract research organizationoutsourced R&Drodent modelselectroencephalographyCNS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SynapCell Comparables

Compare SynapCell with similar companies based on industry and business-model similarity.

SynapCell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
E-Phy-Science
86%
Neuroservices-Alliance
86%
PsychoGenics Inc.
86%

SynapCell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 10, 2023
VC RoundNov 5, 2010
SeedFeb 1, 2009

Key People

Founding team and executive leadership

Yann Roche

Chief Executive Officer, General Manager, Founder - Head Of Research & Innovation

Founding Team

Pierre-Marie Girod-Roux

Chief Operating Officer

Executive Team

SynapCell Investors

Notable investors and investment history

SynapCell investors
InvestorRounds
Grenoble AngelsSeed, VC Round
KreaxiSeed, VC Round
BpifranceGrant
ExpansinvestSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    Monthly visitors grew 450% MoM, reaching 1.1K.

  • Jan 10, 2023

    $1.29M grant received from Bpifrance.

SynapCell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SynapCell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SynapCell's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range41
Year Founded2005
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?